Giving Time Its Meaning: The Humble Dandelion Carries the Great Dream of Rural Revitalization
Amid the hundred-acre fields of Nanniwan Town, Yan'an City, Shaanxi Province, clusters of dandelions sway in the breeze. Behind the sea of green lies JumpCan Pharmaceutical's long-term strategic deployment to address the challenge of sourcing raw materials for TCM and contribute to rural...
JumpCan's Pudilan and Tonpei Named to the "2026 Healthy China · Brand List"
From August 11 to 16, the 19th Health Industry Ecological Platform (CPEO) was held in Boao, Hainan. At the conference, the highly influential industry ranking "2026 Healthy China · Brand List" was officially released. JumpCan Pharmaceutical's Pudilan Xiaoyan Oral Liquid and...
First Chinese Patent Medicine for Pediatric Constipation! JumpCan Pharmaceutical's Class 1.1 Innovative TCM Drug — Xiao'er Tongbian Granules — Approved for Marketing
Innovation-Driven Development! JumpCan Pharmaceutical's independently developed Class 1.1 innovative traditional Chinese medicine (TCM) drug, Xiao'er Tongbian Granules, has officially received marketing approval from the National Medical Products Administration (NMPA). This new product launch...
Good Medicines Benefit the Grassroots! JumpCan Pharmaceutical's Tonpei Included in the New National Essential Medicines List
On July 9, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control and Prevention Administration jointly released the National Essential Medicines List (2026 Edition) (hereinafter referred to as the "National Essential Medicines List")...
First release! New breakthrough of Chinese original research innovative drug Zelimei (Benvitimod Cream)
From June 11 to 14, The 31st Annual Meeting of Chinese Society of Dermatology was held in a grand ceremony at the Capital International Exhibition & Convention Center. During the conference, the results of the first Phase III clinical trial of Zelimei (Benvitimod Cream) — an innovative drug...
JumpCan Pharmaceutical's Minfeile Selected for the Jiangsu Province Clinical Advantage Drug Catalog (First Batch)
The Jiangsu Province Clinical Advantage Drug Catalog (First Batch) (hereinafter referred to as "the Catalog") has recently been officially announced. JumpCan Pharmaceutical's product Minfeile (Fexofenadine Hydrochloride for Suspension) has been successfully selected for inclusion...
Anti-Influenza Class 1 Innovative Drug Jikeshu Approved for Adolescent Indication
On June 8, Jikeshu (INN: Sebaloxavir Marboxil Tablets), a Class 1 innovative anti-influenza drug developed through a strategic collaboration between JumpCan Pharmaceutical and Zenshine Pharmaceuticals, received official approval from the National Medical Products Administration (NMPA)...
World Environment Day: Rooting Downward, Growing Upward
JumpCan has long pursued a development philosophy of environmental stewardship and resource efficiency, treating environmental management as a "lifeline" that stands shoulder to shoulder with workplace safety and quality management. Sustainability isn't an add-on; we build it into every...
Recently, the Symposium on Healthy China and Biomedical Engineering Innovation and the 5th High-Quality TCM Development Conference were grandly held in Tianjin. At the conference, JumpCan Pharmaceutical was awarded the title of "Thirty-Year Demonstration Unit of TCM Modernization," and...